American Diabetes Association: Overcoming Therapeutic Inertia Certificate Program

Therapeutic inertia is the failure to advance or deintensify the treatment regimen when a patient’s therapeutic goals are not met. Earlier achievement of glycemic control is critical for improving outcomes for patients with diabetes. There are simple things you can do right now to more rapidly optimize treatment and to remove barriers to care plan adherence – both essential to busting therapeutic inertia. The ADA's Overcoming Therapeutic Inertia (OTI) CME Certificate program is designed to empower clinicians caring for people with diabetes with knowledge and strategies to be a barrier buster. The OTI Certificate bundle allows clinicians to access all OTI modules at a discounted price in addition to the following exclusive benefits:

  • A one-year ADA professional membership (new members only)
  • Access to seven interactive modules
  • Access to a case-based self-assessment program: Optimize the Diabetes Patient Journey
  • Three exclusive live webinars - More details to follow
This certificate program offers a total of 11.75 CME credits. Please note the three exclusive live webinars are not available yet and the current total CME credit does not reflect the total for the certificate program.

Courses

Purchase the bundle and save or click titles below to purchase separately.
Busting Inertia: Identifying and Engaging High-Risk Patients | 1.0 AAPA Category 1 CME Credits
Timely Therapy Intensification: Tools to Guide Decision-Making at the Point of Care | 1.0 AAPA Category 1 CME Credits
Personalized Diabetes Care Plans that Work | 1.0 AAPA Category 1 CME Credits
Effectively Addressing Emotional Barriers to Diabetes Self-Management | 0.75 AAPA Category 1 CME Credits
Patient Empowerment in Action: Putting Barrier Busting into Practice | 1.0 AAPA Category 1 CME Credits
Leveraging Diabetes Education and Community Resources as an Inertia Buster | 0.75 AAPA Category 1 CME Credits
Optimize the Diabetes Patient Journey: A Case-Based Approach for Busting Inertia | 0.75 AAPA Category 1 CME Credits
Optimize the Diabetes Patient Journey: A Case-Based Self-Assessment Program | 2.5 AAPA Category 1 Self-Assessment CME Credits

Learning Objectives
Busting Inertia: Identifying and Engaging High-Risk Patients
  • Improve understanding of the importance of identifying patients likely affected by therapeutic inertia (TI)
  • Increase confidence in identifying patients experiencing therapeutic inertia through the use of electronic health record queries and other methods
  • Increase confidence in the ability to utilize patient dashboards and best practice alerts as tools to overcome TI
  • Ability to list at least 3 patient engagement tactics that can be utilized within a practice to help overcome TI and improve treatment adherence
Timely Therapy Intensification: Tools to Guide Decision-Making at the Point of Care
  • Understand evidence supporting the legacy effect of reaching glycemic targets and A1C goal quickly after diagnosis
  • Describe the optimal process for intensifying and deintensifying medication therapy that quickly and effectively yields optimal diabetes targets in type 2 diabetes
  • Define how decision support tools and technology can be used to assist the patient-provider team in achieving glycemic targets and overall health
Personalized Diabetes Care Plans that Work
  • Increase understanding of the role personalized diabetes care plans play in overcoming therapeutic inertia
  • Improve understanding of the medical, social, emotional, and patient-preference factors that need to be considered in developing an effective personalized diabetes care plan
  • Define the components of high-quality personalized diabetes care and management plan
  • Improve confidence in creating an effective personalized diabetes care plan
Effectively Addressing Emotional Barriers to Diabetes Self-Management
  • Increased understanding of the impact of emotional and social factors on diabetes self-care
  • Improved ability to identify and distinguish between depression and diabetes distress in people with type 2 diabetes
  • Ability to identify the components of a successful plan to address emotional barriers impacting diabetes self-care
Patient Empowerment in Action: Putting Barrier Busting into Practice
  • Identify ways to leverage the entire care team to help reduce therapeutic inertia
  • Understand how to structure an effective “diabetes only” visit
  • Improve understanding of how effective care coordination can help overcome therapeutic inertia
  • Improve understanding of optimal time frames for scheduling a follow-up visit based on A1C and medication changes
  • Describe how virtual care can be utilized to help overcome therapeutic inertia
Leveraging Diabetes Education and Community Resources as an Inertia Buster
  • Assess patient-level barriers to diabetes self-care and care plan follow through
  • Describe the four critical times to refer to Diabetes Self- Management Education and Support (DSMES)
  • Identify the steps in an effective referral for DSMES and medical nutrition therapy (MNT)
  • Locate relevant community support resources to address social and emotional barriers contributing to therapeutic inertia
Optimize the Diabetes Patient Journey: A Case-Based Approach for Busting Inertia
  • Ability to implement a patient-centered diabetes care plan and an A1C-based follow-up algorithm
  • Understanding of which medications to use for post-prandial and fasting glucose improvement
  • Confidence in applying the ADA Standards of Medical Care in Diabetes to reduce therapeutic inertia in a patient with type 2 diabetes
  • Ability to describe the benefits of remote patient monitoring
Optimize the Diabetes Patient Journey: A Case-Based Self-Assessment Program
  • Detect barriers contributing to therapeutic inertia in patient
  • Identify appropriate interventions, approaches and tools that reduce therapeutic inertia
  • Identify ways to modify and individualize diabetes management plans to overcome therapeutic inertia and support improved glycemic control
Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Novo Nordisk  & Merck Co., Inc.

AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.